https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-05-24 / Neurol. Med. Chir. (Tokyo) 2017 Jul;57(7):321-330
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-05-24 / Neurol. Med. Chir. (Tokyo) 2017 Jul;57(7):321-3302017-05-24 00:00:002019-02-15 08:36:10Prospect of Immunotherapy for Glioblastoma: Tumor Vaccine, Immune Checkpoint Inhibitors and Combination Therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-05-23 / Cancer Res. 2017 08;77(15):4146-4157
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-05-23 / Cancer Res. 2017 08;77(15):4146-41572017-05-23 00:00:002019-02-15 09:23:10Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-05-20 / Int J Mol Sci 2017 May;18(5)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-05-20 / Int J Mol Sci 2017 May;18(5)2017-05-20 00:00:002021-11-15 16:51:51Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-05-17 / Cell J 2017;19(Suppl 1):79-85
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-05-17 / Cell J 2017;19(Suppl 1):79-852017-05-17 00:00:002017-05-17 00:00:00Enhanced DNA Damages of Human Prostate Cancer Cells Induced by Radiofrequency Capacitive Hyperthermia Pre- and Post X-rays: 6 MV versus 15 MV
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-05-17 / Cell J 2017;19(Suppl 1):86-95
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-05-17 / Cell J 2017;19(Suppl 1):86-952017-05-17 00:00:002017-05-17 00:00:00The Role of Radiofrequency Hyperthermia in The Radiosensitization of A Human Prostate Cancer Cell Line
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-05-16 / Oncotarget 2017 05;8(20):33897-33910
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-05-16 / Oncotarget 2017 05;8(20):33897-339102017-05-16 00:00:002019-02-15 08:47:54Immunotherapeutic approaches for hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-05-15 / Front Immunol 2017;8:555
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-05-15 / Front Immunol 2017;8:5552017-05-15 00:00:002019-02-15 09:23:11Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future Perspectives
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-05-12 / J Transl Med 2017 05;15(1):104
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-05-12 / J Transl Med 2017 05;15(1):1042017-05-12 00:00:002019-02-15 08:47:31A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-05-12 / Nat Rev Neurol 2017 Jun;13(6):363-374
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-05-12 / Nat Rev Neurol 2017 Jun;13(6):363-3742017-05-12 00:00:002019-02-15 08:47:30Vaccine-based immunotherapeutic approaches to gliomas and beyond
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-05-12 / Oncoimmunology 2017;6(7):e1328341
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-05-12 / Oncoimmunology 2017;6(7):e13283412017-05-12 00:00:002019-02-15 08:45:19Trial watch: Dendritic cell-based anticancer immunotherapy
